Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders.
暂无分享,去创建一个
Christoph Hiemke | David W Bates | Johannes Lotz | D. Bates | K. Lackner | J. Lotz | C. Hiemke | Karl J Lackner | L. Schmidt | Klaus Mann | Lutz G Schmidt | K. Mann
[1] D. Bates. Improving the use of therapeutic drug monitoring. , 1998, Therapeutic drug monitoring.
[2] F. Bochner,et al. Therapeutic Drug Monitoring and Patient Outcome , 1994, Clinical pharmacokinetics.
[3] B Müller-Oerlinghausen,et al. The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry , 2004, Pharmacopsychiatry.
[4] R. Schlienger,et al. Appropriateness of serum level determinations of antiepileptic drugs. , 2003, Swiss medical weekly.
[5] C. Naylor,et al. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. , 1998, JAMA.
[6] H. Hinterhuber,et al. What the clinician still has to be reminded of. , 2004, Therapeutic drug monitoring.
[7] F. Vuille,et al. Use of Plasma Level Monitoring of Antidepressants in Clinical Practice , 1991, Pharmacopsychiatry.
[8] D W Bates,et al. Appropriateness of antiepileptic drug level monitoring. , 1995, JAMA.
[9] G J Kuperman,et al. What proportion of common diagnostic tests appear redundant? , 1998, The American journal of medicine.
[10] G J Kuperman,et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. , 1999, The American journal of medicine.